Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease that is mainly diagnosed based on its clinical symptoms. Biomarkers that could facilitate the diagnosis of ME/CFS are not yet available; therefore, reliable and clinically useful disease indicators are of high importanc...
Main Authors: | Sabine Gravelsina, Anda Vilmane, Simons Svirskis, Santa Rasa-Dzelzkaleja, Zaiga Nora-Krukle, Katrine Vecvagare, Angelika Krumina, Iana Leineman, Yehuda Shoenfeld, Modra Murovska |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.928945/full |
Similar Items
-
Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
by: Sabine Gravelsina, et al.
Published: (2021-08-01) -
The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome
by: Santa Rasa-Dzelzkaleja, et al.
Published: (2023-01-01) -
Circulating miRNAs Expression in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Irene Soffritti, et al.
Published: (2023-06-01) -
Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
by: Vincenzo Di Stefano, et al.
Published: (2022-10-01) -
Role of complement in myasthenia gravis
by: Pyae Phyo San, et al.
Published: (2023-10-01)